These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7252521)

  • 21. Ultrastructural localization of the terminal and lytic ninth complement component (C9) at the motor end-plate in myasthenia gravis.
    Sahashi K; Engel AG; Lambert EH; Howard FM
    J Neuropathol Exp Neurol; 1980 Mar; 39(2):160-72. PubMed ID: 7373347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of myasthenic immunoglobulin G on motor end-plate morphology.
    Tsujihata M; Satoh A; Yoshimura T; Motomura M; Takeo G; Matsuo H; Nakamura T
    J Neurol; 2003 Jan; 250(1):75-82. PubMed ID: 12527996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of corticosteroids on the motor end-plate fine structure in experimental autoimmune myasthenia gravis rats and normal rats].
    Satoh A; Tsujihata M; Takashima H; Hazama R; Nagataki S
    Rinsho Shinkeigaku; 1985 Aug; 25(8):990-1000. PubMed ID: 3877587
    [No Abstract]   [Full Text] [Related]  

  • 24. Congenital myasthenic syndromes in two kinships with end-plate acetylcholine receptor and utrophin deficiency.
    Sieb JP; Dörfler P; Tzartos S; Wewer UM; Rüegg MA; Meyer D; Baumann I; Lindemuth R; Jakschik J; Ries F
    Neurology; 1998 Jan; 50(1):54-61. PubMed ID: 9443457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neostigmine-induced end-plate proliferation in the rat. A study using supra-vital methylene blue.
    Schwartz MS; Sargeant MK; Swash M
    Neurology; 1977 Mar; 27(3):289-93. PubMed ID: 66646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuromuscular transmission in neonatal mice injected with serum globulin of myasthenia gravis patients.
    Pagala MK; Tada S; Namba T; Grob D
    Neurology; 1982 Jan; 32(1):12-7. PubMed ID: 6275304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acetylcholine release in myasthenia gravis: regulation at single end-plate level.
    Plomp JJ; Van Kempen GT; De Baets MB; Graus YM; Kuks JB; Molenaar PC
    Ann Neurol; 1995 May; 37(5):627-36. PubMed ID: 7755358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Duchenne dystrophy: ultrastructural localization of the acetylcholine receptor and intracellular microelectrode studies of neuromuscular transmission.
    Sakakibara H; Engel AG; Lambert EH
    Neurology; 1977 Aug; 27(8):741-5. PubMed ID: 196235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrastructural localization of immune complexes (IgG and C3) at the end-plate in experimental autoimmune myasthenia gravis.
    Sahashi K; Engel AG; Linstrom JM; Lambert EH; Lennon VA
    J Neuropathol Exp Neurol; 1978; 37(2):212-23. PubMed ID: 147324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of prednisolone on motor end-plate fine structure: a morphometric study in hamsters.
    Chokroverty S; Reyes MG; Chokroverty M; Kaplan R
    Ann Neurol; 1978 Apr; 3(4):358-65. PubMed ID: 666278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphological observations on motor end-plates in rabbits with experimental myasthenia.
    Thornell LE; Sjöström M; Mattsson CH; Heilbronn E
    J Neurol Sci; 1976 Oct; 29(2-4):389-410. PubMed ID: 978217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of the opiate antagonist, naltrexone methyl bromide, with the acetylcholine receptor system of the motor end-plate.
    Argentieri TM; McArdle JJ
    Brain Res; 1983 Oct; 277(2):377-9. PubMed ID: 6640302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deficiency of acetylcholine receptors in a case of end-plate acetylcholinesterase deficiency: a histochemical investigation.
    Jennekens FG; Hesselmans LF; Veldman H; Jansen EN; Spaans F; Molenaar PC
    Muscle Nerve; 1992 Jan; 15(1):63-72. PubMed ID: 1732764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The contribution of postsynaptic folds to the safety factor for neuromuscular transmission in rat fast- and slow-twitch muscles.
    Wood SJ; Slater CR
    J Physiol; 1997 Apr; 500 ( Pt 1)(Pt 1):165-76. PubMed ID: 9097941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Refractoriness to a second episode of experimental myasthenia gravis. Correlation with AChR concentration and morphologic appearance of the postsynaptic membrane.
    Corey AL; Richman DP; Agius MA; Wollmann RL
    J Immunol; 1987 May; 138(10):3269-75. PubMed ID: 3494763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The neuromuscular junction: recent developments.
    Bowman WC
    Eur J Anaesthesiol; 1985 Mar; 2(1):59-93. PubMed ID: 2410263
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of carbacholine on miniature potentials and currents of rat skeletal muscle endplates].
    Nikol'skiĭ EE
    Neirofiziologiia; 1982; 14(2):185-9. PubMed ID: 6283403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-function correlations in myasthenia gravis and a new myasthenic syndrome.
    Engel AG; Lambert EH
    Electroencephalogr Clin Neurophysiol Suppl; 1978; (34):469-77. PubMed ID: 220007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Limb muscle endplates in ocular myasthenia gravis: quantitative ultrastructural study.
    Tsujihata M; Hazama R; Ishii N; Ide Y; Mori M; Takamori M
    Neurology; 1979 May; 29(5):654-61. PubMed ID: 571563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultrastructural study of the motor end-plate in botulism and Lambert-Eaton myasthenic syndrome.
    Tsujihata M; Kinoshita I; Mori M; Mori K; Shirabe S; Satoh A; Nagataki S
    J Neurol Sci; 1987 Nov; 81(2-3):197-213. PubMed ID: 3694228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.